Literature DB >> 10714194

Classification of gastritis--yesterday, today and tomorrow.

A B Price1.   

Abstract

The major landmark in the recent history of gastritis was the discovery of Helicobacter pylori as the cause for approximately 90% of cases of chronic gastritis. This was followed by an attempt to rationalise classification from the many conflicting nomenclatures in existence to one, the Sydney System, that might gain more universal acceptance and allow studies from around the world to be compared. In the decade since its inception, including an appropriate update, the system has partially achieved this aim. It is based on documenting the topography of the gastritis, this reflecting the range of possible clinical outcomes and point of progress along the gastritis-metaplasia-dysplasia-carcinoma cascade. The rapidly expanding molecular knowledge about host mucosal immunology, determinants of bacterial virulence and dietary constituents makes it likely "tomorrow's" classification will be an algorithm to include several such factors. From this an exact "peptic" patient profile could be constructed. However one must also speculate that interest in gastritis and its classification could whither just as quickly as it blossomed with the advent of a successful vaccine.

Entities:  

Mesh:

Year:  1999        PMID: 10714194

Source DB:  PubMed          Journal:  Verh Dtsch Ges Pathol        ISSN: 0070-4113


  3 in total

1.  Effects of bile reflux on gastric mucosal lesions in patients with dyspepsia or chronic gastritis.

Authors:  Sheng-Liang Chen; Jian-Zhong Mo; Zhi-Jun Cao; Xiao-Yu Chen; Shu-Dong Xiao
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

2.  A study of Helicobacter pylori-associated gastritis patterns in Iraq and their association with strain virulence.

Authors:  Nawfal R Hussein; Sarbar M Napaki; John C Atherton
Journal:  Saudi J Gastroenterol       Date:  2009-04       Impact factor: 2.485

3.  Primary antibiotic resistance and associated mechanisms in Helicobacter pylori isolates from Senegalese patients.

Authors:  Abdoulaye Seck; Christophe Burucoa; Daouda Dia; Mouhamadou Mbengue; Manuella Onambele; Josette Raymond; Sebastien Breurec
Journal:  Ann Clin Microbiol Antimicrob       Date:  2013-01-08       Impact factor: 3.944

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.